882 results about "Normal range" patented technology

Vehicle including a seat in which an occupant sits during use of the vehicle and a monitoring system for monitoring the occupant in the seat. The monitoring system includes sets of electric field antennas, each including at least one antenna, a control unit connected to the antenna sets and including selectors coupled to the antennas. The selectors are controlled by the control unit to obtain signals from one or more antennas serving as receiving antennas and one or more antennas serving as sending antennas. The control unit determines which combination of sending antenna(s) and receiving antenna(s) provides a strongest signal in an expected heartbeat range and/or expected respiration range of the occupant and then monitors this combination for changes and/or deviations from a normal range of heartbeats and/or respiration.

A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.

An intuitive graphical display as described herein can be rendered by a host device that obtains physiological patient data (such as blood glucose values) in real time or substantially real time. The graphical display includes a calibrated bar graph having a desired measurement range for the monitored parameter. The graphical display also includes a dynamic measurement value indicator that moves along the bar graph in a manner that tracks the current value of the monitored physiological characteristic. The graphical display may also incorporate easy-to-interpret display elements that allow the user to quickly determine whether the current value of the monitored physiological characteristic is within or outside a normal range, whether the monitored physiological characteristic is rising or falling, and the approximate rate of change of the monitored physiological characteristic.

The invention discloses a method for processing audio stream playback in the network terminal buffer zone for solving the problem of voice pausing and jamming in the network communication. The aim of the invention is achieved by performing real time audio (e.g. voice) communication on the packet-switching network (e.g. IP network), arranging a shake buffer zone on the receiving end, after the receiving end receives the audio package, it first performs decoding based on the normal sequence, then places it into the shake buffer zone, when the shake buffer zone is to be filled, lower the sampling rate to the audio data to realize the fast playback of the audio data stream, when the shake buffer zone is to be empty, raise the sampling rate to the audio data to realize the low speed playback of the audio data stream, when the audio data in the shake buffer is within the normal range, playback the audio stream with the original sampling rate.

A patient monitoring and intervention system, comprises an interface for receiving data representing multiple different parameters from multiple different sensors, comprising sensors in a patient bed and attached to a patient including, a heart rate sensor, a respiration sensor and a pressure sensor indicating bed pressure points. A learning processor determines a normal range for a set of the different received patient parameters for the patient by recording the patient parameter values over a time period and analyzing the recorded parameter values to determine their range. A data processor determines if the set of different received patient parameters exceeds the determined normal range and in response to this determination and in response to the type of parameters in the set and medical record information of the patient, initiates adjustment of a patient bed and at least one of, (a) changes medication administered to a patient and (b) alerts a worker of the patient parameter change.

The present invention is a personal health monitoring system which interactively delivers treatment stimuli and compiles a chronological history of a patient's health. The invention includes personal health diaries for direct measurement of physiological measurement as well as collection subjective responses. The personal health diaries also deliver educational content and health related reminders. The personal health diaries are remotely configured to deliver patient specific display of the treatment information. Patient response information, timing signals are routinely transmitted to the central monitoring system. The central monitoring system is programmed to automatically alert caregivers and family members when responses fall outside patient defined normal ranges. Caregivers and family members can interactive with the central monitoring system to provide updated treatment information as well as personal inspirational content. Through education and appropriate intervention the present invention can improve and maintain the patient's health and extend their independent lifestyle.

The present invention relates to methods and systems for providing an animal with a nutraceutical program that is specifically tailored to address the deficiencies and/or needs of the particular animal. Blood is drawn from the animal and analyzed at a lab to obtain blood test results. The blood test results are scored to obtain at least one blood test score for at least one corresponding blood parameter. If the at least one blood test score falls within a normal range but outside of an optimal range, one or more nutraceuticals needed to bring the animal within the optimal range for the at least one corresponding blood parameter are identified. A prescribed dosage amount is then calculated for at least one of the one or more identified nutraceuticals for the animal. The calculation of the prescribed dosage amount is based on at least the blood test score for the corresponding blood parameter and a deviation of the blood test score from the optimal range.

A method and adjustable apparatus for stabilizing and strengthening the shoulder muscles and rotator cuff provides an active range of motion activities that can be performed with or without resistance. In particular, the method and apparatus provide for scapular retraction and protraction, shoulder flexion, extension, adduction and abduction, as well as internal and external shoulder rotation, performed horizontally and vertically. All of these motions are beneficial to the shoulder joint because they allow the joint to move freely throughout its normal range of motion using natural mechanics of the rotator cuff and surrounding muscles. The method and apparatus provide the essential benefit of stabilizing the shoulder and rotator cuff throughout these motions so that the user's range of motion and strength building is optimized. The method and apparatus also provide for self myofascial release techniques to decrease spasm.

In a method for making a low-defect single-crystal GaN film, an epitaxial nitride layer is deposited on a substrate. A first GaN layer is grown on the epitaxial nitride layer by HVPE under a growth condition that promotes the formation of pits, wherein after growing the first GaN layer the GaN film surface morphology is rough and pitted. A second GaN layer is grown on the first GaN layer to form a GaN film on the substrate. The second GaN layer is grown by HVPE under a growth condition that promotes filling of the pits, and after growing the second GaN layer the GaN film surface morphology is essentially pit-free. A GaN film having a characteristic dimension of about 2 inches or greater, and a thickness normal ranging from approximately 10 to approximately 250 microns, includes a pit-free surface, the threading dislocation density being less than 1×10⁸ cm⁻².

The invention discloses a percutaneous closed-loop control charging device for implantation type medical treatment instrument and belongs to the technical field of implantation medical instrument. The percutaneous closed-loop control charging device for implantation type medical treatment instrument comprises an external charger and an internal implantation type medical instrument. An external energy transmitting coil is a large-size flat magnetic core coil, and an internal energy receiving coil is a hollow coil; the external energy transmitting coil transmits electromagnetic energy by adopting a resonance electromagnetic coupling manner with parallel central shafts; and the electrical energy obtained by the internal energy receiving coil charges an internal rechargeable battery through an internal charge control circuit. The closed-loop control charging device communicates in a pulse position modulation manner for closed-loop control to ensure the energy received by the implantation medical instrument in different charging phases to be within the normal range, effectively control the heating and increase the safety; the closed-loop control charging device calculates the efficiency by the internal feedback parameter to realize counterpoint prompt and increase the charging efficiency. The percutaneous wireless charging method can charge the implantation type medical instrument by a titanium casing, is safe and reliable in charging, and can be applied to all types of implantation type medical instruments equivalent to a deep brain stimulator in power level.

An automatic transmission power control circuit which can detect an abnormality in a transmission power without a comparing circuit which compares a detected voltage with reference voltages. A detector detects a voltage corresponding to the transmission power and outputs a detected voltage. A comparator compares the detected voltage with a reference voltage so that the transmission power is controlled based on an output of the comparator. A transmission power abnormality detecting circuit includes a counter which cumulates the output of the comparator. The transmission power abnormality detecting circuit outputs a transmission power abnormality detection signal when an output of the counter is a value which is out of a normal range when the automatic power transmission control circuit is normally functioning.

In one aspect, the present invention is directed to a method for operating an electronically controlled internal combustion engine in a vehicle to perform at least one rationality check on at least one sensor to detect impending sensor failure and verify component functionality. The engine is equipped with an engine control system (ECS) having a memory and in electronic communication with various sensors. The sensors transmit data signals to the ECS indicative of associated engine and vehicle component functionality. The method comprises determining a measured operating condition of a first component from sensor data signals indicative of first component functionality, determining a measured operating condition of a second component from sensor data signals indicative of second component functionality, comparing the measured condition of the first component to the measured operating condition of the second component to determine whether sensor readings from the first component are indicative of a component operating within a normal range but indicative of impending sensor or component failure, logging an indication of an impending sensor or component failure as a fault in MPU memory if it occurs for a predetermined period of time and for more than a predetermined number of times and drive cycles, and activating a warning alert to an operator and initiating remedial actions responsive to the indication of impending component or sensor failure. The data logged includes time of fault, type of fault, number of occurrences of the fault, number of drive cycles where the fault occurred and distance traveled with the fault logged.

The present invention is directed to a method and system for use in a computing environment to monitor parameters and detect abnormalities. A monitoring system for monitoring a process may include a signature creation module for creating a signature representative of the process, a signature updating module for continuously updating the created signature, and an abnormality detection module for detecting abnormalities based upon deviations from the updated signature. The system may perform a method for detecting abnormalities occurring during a process based upon the continuously updated signature representative of the process. The method may include continuously monitoring a system parameter and computing a normal range of values for the system parameter based on the continuously updated signature. The method may additionally include determining if the monitored system parameter is within the normal range and indicating existence of an abnormality if the monitored system parameter is outside of the normal range.

Various embodiments of the present disclosure provide dual CTS protection (DCTS) systems and methods. One method embodiment, among others, comprises receiving a first frame of a transmit opportunity (TXOP), and sending a short frame with a modulation that depends on whether the first frame is an extended range or normal range frame.

A system, method, and apparatus are disclosed whereby a wireless Personal Area Network such as a Bluetooth piconet may be extended to a remote location beyond the normal range by means of a conferencing connection. The conferencing connection may comprise, for example, one or more ISDN lines or an IP connection between two or more conference endpoints. The broadband connection may include a video channel, an audio channel, a control channel, and a Bluetooth channel.

An operation management apparatus monitors the performance information of a system executing services and extracts correlation variants of the performance information, thus allowing the management to detect and localize performance-degrading faults of the system. It is determined whether or not the range of correlation collapse ascribed to the performance information falls within the normal range of correlation collapse measured in the normal operation of the system. A history is retained with regard to the range of correlation collapse ascribed to the performance information which does not fall within the normal range of correlation collapse. It is determined whether or not the history accumulating the predetermined number of ranges of correlation collapse approximates to the fault range of correlation collapse measured in the faulty operation of the system, thus discriminating a fault model on the basis of the performance information.

A fault diagnosis section activates a driving compornent alone, measures an operation state signal and a paper passage time, and stores feature values (Vm, σv, Tqs, σts) extracted as a determination reference in a storage medium. A paper passage fault determination section determines whether or not a fault has arisen on the basis of the paper passage time when an apparatus is under normal operating conditions. A diagnosis target block determination section determines an order to operate a detail fault diagnosis when it is determined that there is a plurality of diagnosis target blocks. When the driving compornent is activated alone under actual operation conditions, the operation state signal Vf is obtained, and an operation state fault determination section conducts diagnosis on whether or not a fault has arisen on the driving compornent and a state of the fault, and whether or not a fault has arisen on other power transmission compornents and a nature of the fault with reference to the feature values as the determination reference on the basis of a degree of deviation from a normal range.

A heart monitor is disclosed. The monitor computes ST segment deviations and stores the results in heart rate based histograms. Periodically, the monitor analyzes the histogram data to determine a normal range of ST deviation for a particular heart rate range. The monitor computes heart rate dependent ischemia detection thresholds based on the upper and lower boundaries of the normal range.

The invention discloses a wearable device and an emotion reminding method. The wearable device comprises a controller, a heart rate detection circuit, an impedance detection circuit and a body temperature detection circuit, wherein at least one of the heart rate detection circuit, the impedance detection circuit and the body temperature detection circuit is connected with the controller, and the heart rate detection circuit, the impedance detection circuit and the body temperature detection circuit are used for detecting the heart rate, the respiratory rate, the body impedance and the body temperature variation of a user respectively. The wearable device further comprises an accelerated speed detection circuit and a reminding circuit, wherein the accelerated speed detection circuit and the reminding circuit are connected with the controller. The controller is used for detecting detection results of the detection circuits and judging whether the detection results are beyond the respective corresponding normal ranges. The accelerated seed detection circuit is used for judging whether the user is in a motion state at present when at least one detection result is beyond the normal range corresponding to the detection result. The reminding circuit is used for sending out a prompt message when the user is not in the motion state. Accordingly, the wearable device can detect unhealthy emotions of the user in time and remind the user.